Free Trial

Daniel Grosslight Analyst Performance

Analyst at Citigroup

Daniel Grosslight is a stock analyst at Citigroup, covering 15 publicly traded companies across a range of sectors. Over the past year, Daniel Grosslight has issued 14 stock ratings, including buy and hold recommendations. While full access to Daniel Grosslight's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Grosslight's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
24 Last 5 Years
Buy Recommendations
72.73% 16 Buy Ratings
Companies Covered
15 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy72.7%16 ratings
Hold27.3%6 ratings
Sell0.0%0 ratings

Out of 22 total stock ratings issued by Daniel Grosslight at Citigroup, the majority (72.7%) have been Buy recommendations, followed by 27.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
53.3% of companies on NASDAQ
8 companies
NYSE
46.7% of companies on NYSE
7 companies

Daniel Grosslight, an analyst at Citigroup, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
11 companies
73.3%
Computer and Technology
3 companies
20.0%
Finance
1 company
6.7%

Daniel Grosslight of Citigroup specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Finance companies.

Coverage Industries

IndustryPercentage
MEDICAL INFO SYS
2 companies
13.3%
INTERNET SOFTWARE
2 companies
13.3%
MED/DENTAL - SUPP
2 companies
13.3%
MEDICAL SERVICES
2 companies
13.3%
DATA PROCESSING & PREPARATION
2 companies
13.3%
MED PRODUCTS
1 company
6.7%
BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED
1 company
6.7%
OFFICES & CLINICS OF MEDICAL DOCTORS
1 company
6.7%
COMPUTER PROGRAMMING, DATA PROCESSING, & OTHER COMPUTER RELATED
1 company
6.7%
INS - BROKERS
1 company
6.7%

Daniel Grosslight's Ratings History at Citigroup

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
8/12/2025Reiterated Rating$4.65$7.00Buy
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
8/8/2025Downgrade$2.83$3.50Neutral
Waystar Holding Corp. stock logo
WAY
Waystar
6/25/2025Initiated Coverage$38.71$45.00Buy
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
6/13/2025Reiterated Rating$160.43$170.00Neutral
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
4/25/2025Lower Price Target$4.01$6.50Buy
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
4/25/2025Lower Price Target$7.20$8.75Neutral
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
4/17/2025Lower Price Target$6.93$11.00Buy
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
1/10/2025Boost Price Target$122.56$129.00Neutral
Evolent Health, Inc stock logo
EVH
Evolent Health
1/10/2025Lower Price Target$12.46$18.00Buy
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
1/10/2025Lower Price Target$4.49$6.25Buy
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1/10/2025Lower Price Target$6.93$10.00Buy
McKesson Corporation stock logo
MCK
McKesson
1/10/2025Lower Price Target$587.93$677.00Buy
MultiPlan Co. stock logo
MPLN
MultiPlan
1/10/2025Boost Price Target$12.15$12.50Neutral
Phreesia, Inc. stock logo
PHR
Phreesia
1/10/2025Boost Price Target$26.32$35.00Buy